| Application no. and date | 21216409.9 (espacenet) (Federated) (European Patent Register), 20150206 | | Patent/reg. no. and date | DK/EP 4049681, 20260107 | | Publication date | 20220831 | | Priority no. and date | US 201461937223 P, 20140207 | | EP pub. no. and date |
EP 4049681 20220831 | | Effective date | | | Applicant/owner | Neurocrine Biosciences, Inc., 6027 Edgewood Bend Court
San Diego, CA 92130, US | | Applicant ref. no. | | | Inventor | HOARE, Samuel Roger Jesse,
San Diego, 92116, US | | Representative | | | Opponent | | | IPC Class | A61K 31/473 (2006.01) , A61K 31/4745 (2006.01) , A61K 31/519 (2006.01) , A61K 31/551 (2006.01) , A61K 31/5513 (2006.01) , A61K 45/06 (2006.01) , A61P 25/18 (2006.01) , A61P 25/24 (2006.01) , A61P 43/00 (2006.01) | | Title | PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR AND USES THEREOF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
